Geode Capital Management
SNTI icon

Geode Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Geode Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$206K Sell
187,065
-19,978
-10% -$19.5K ﹤0.01% 3908
2026
Q1 		$168K Buy
207,043
+62,246
+43% +$60.2K ﹤0.01% 3976
2025
Q4 		$151K Sell
144,797
-8,041
-5% -$14.2K ﹤0.01% 3997
2025
Q3 		$216K Buy
152,838
+5,524
+4% +$9.23K ﹤0.01% 3900
2025
Q2 		$311K Buy
147,314
+117,588
+396% +$372K ﹤0.01% 3722
2025
Q1 		$99.9K Buy
29,726
+2,232
+8% +$8.69K ﹤0.01% 4031
2024
Q4 		$96.5K Buy
27,494
+201
+0.7% +$642 ﹤0.01% 4106
2024
Q3 		$61.7K Buy
27,293
+2,734
+11% +$7.22K ﹤0.01% 4221
2024
Q2 		$67.8K Hold
24,559
– – ﹤0.01% 4222
2024
Q1 		$92.6K Buy
24,559
+718
+3% +$3.21K ﹤0.01% 4183
2023
Q4 		$157K Hold
23,841
– – ﹤0.01% 4022
2023
Q3 		$101K Buy
23,841
+3,822
+19% +$26.3K ﹤0.01% 4246
2023
Q2 		$125K Hold
20,019
– – ﹤0.01% 4248
2023
Q1 		$236K Hold
20,019
– – ﹤0.01% 3960
2022
Q4 		$282K Buy
20,019
+3,291
+20% +$80.3K ﹤0.01% 3923
2022
Q3 		$362K Buy
16,728
+13,916
+495% +$274K ﹤0.01% 3900
2022
Q2 		$55K Hold
2,812
– – ﹤0.01% 4754
2022
Q1 		$277K Sell
2,812
-955
-25% -$94.3K ﹤0.01% 4217
2021
Q4 		$371K Buy
3,767
+351
+10% +$35K ﹤0.01% 4192
2021
Q3 		$339K Hold
3,416
– – ﹤0.01% 4206
2021
Q2 		$339K Buy
+3,416
New +$341K ﹤0.01% 4109

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $357M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Geode Capital Management's SNTI Position: Q2 2026 in Review

Geode Capital Management reduced its Senti Biosciences Holdings (SNTI) stake by 9.6% in Q2 2026, selling an estimated $19.5K and leaving 187,065 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #3908.

Geode Capital Management first reported a position in SNTI in Q2 2021 and has held it in 21 quarters since. The position peaked at $371K in Q4 2021. 19 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

  • Geode Capital Management held 187,065 shares of Senti Biosciences Holdings worth $206K as of Q2 2026.
  • Geode Capital Management sold 19,978 Senti Biosciences Holdings shares in Q2 2026, an estimated $19.5K.
  • Senti Biosciences Holdings made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3908 holding.
  • Geode Capital Management first reported a position in Senti Biosciences Holdings in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Senti Biosciences Holdings position peaked at $371K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.